| Value | ₹3.09 Cr |
|---|
BSE filing, NSE: LORDSCHLO. Summary written from the filing by ALFA Finder's alert engine.
Lords Chloro Alkali Ltd: key numbers
- Share price
- ₹136.88
- Market cap
- ₹392.2 Cr
- Revenue (annual)
- ₹390.1 Cr
- Net profit (annual)
- ₹28.49 Cr
- P/E (TTM)
- 11.9×Sector 26.4×
- Promoter holding
- 74.97%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lords Chloro Alkali Ltd
All →Lords Chloro Alkali Earnings Call Transcript: Key Takeaways
Management is mitigating sharp caustic soda price erosion through aggressive cost-efficiency and record volumes. High renewable energy mix (40%) and captive solar are insulating margins against commodity cycles.
Lords Chloro Alkali Investor Presentation: Key Takeaways
Q2 FY27 income from operations ₹115.40 Cr (+17.34% YoY), PAT flat at ₹9.02 Cr. EBITDA margin fell 464 bps to 16.29% on lower caustic soda realisations. H1 PAT rose 23% to ₹23.97 Cr.
Lords Chloro Alkali Results Update
Lords Chloro Alkali reported Q2 FY27 Total Income of Rs. 115.51 crore, up 14.62% YoY, with PAT of Rs. 9.02 crore. Media release covers H1 FY27 highlights and a new 14.5 MW captive solar commissioning.
Lords Chloro Alkali Q2 FY27 Results: Net Profit ₹9 Cr, Up 0.0% YoY
Lords Chloro Alkali's board approved unaudited results for the quarter and half year ended September 30, 2026. Statutory auditors issued a limited review report on the results.
- Key figure
- Net profit ₹9 Cr · +0.0% YoY
Lords Chloro Alkali Board Meeting Date
Lords Chloro Alkali has scheduled its Board Meeting for 3 November 2026 to consider Q2 and H1 2026-27 un-audited results. The trading window remains closed from 1 October 2026.
Lords Chloro Alkali Other Announcement
Lords Chloro Alkali Ltd has submitted its quarterly shareholding pattern report. This disclosure details the equity distribution between promoter and public shareholders for the period ending September 2026.
Other acquisition announcements
All →Kerala Ayurveda Acquisition
Kerala Ayurveda's subsidiary Nutraveda gained control of PT Kerala Ayurveda Bali through a novation effective October 29, 2026. No consideration was paid, and its 50% shareholding is unchanged.
Jio Financial Services Acquisition Worth ₹123 Cr
Jio Financial invested Rs 123 crore in its 50:50 JV with BlackRock via a rights issue. The arm's-length related-party deal needs no regulatory approval.
- Value
- ₹123.0 Cr
Cyber Media Research & Services Acquisition Worth ₹0.2 Cr
Cyber Media converted CCDs into 2,000 APL shares at Rs.1,000 each, lifting its stake to 23.80%. APL becomes an associate, with related-party terms at arm's length.
- Value
- ₹0.20 Cr
3B BlackBio Dx Acquisition Worth ₹2.8 Cr
Coris, 3B's Belgian subsidiary, will acquire 100% of Bilex SRL for ₹2.80 Crore. The deal ends rent payments, saving about €140,000 yearly.
- Value
- ₹2.80 Cr
LT Foods Acquisition Worth ₹53.94 Cr
LT Foods' US subsidiary will buy 100% of MK Foods, owner of Maya Kaimal, for USD 5.8 million. Completion is expected within three months, paid in cash.
- Value
- ₹53.94 Cr
- Execution
- Within 3 months
Piramal Pharma Acquisition
Piramal Pharma exercised a call option to acquire the remaining 26% stake in subsidiary Yapan Bio. Final consideration and transfer date are yet to be finalised.